ClinicalTrials.gg
RecruitingNCT06676189MEPCATUpdated Jan 17, 2025

Comparison of Pivotal Medial Polyethylene Versus Ultra-congruent in Total Knee Arthroplasty

An interventional study of total knee arthroplasty with medial pivot polyethylene and total knee arthroplasty with ultra-congruent polyethylene in Total Knee Replacement, Primary Knee Replacement and Gonarthrosis, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 1 site in France. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-01-17.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2024, registered Oct 2024).
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Osteoarthritis, Knee by University Hospital, Clermont-Ferrand — 3 open to participants now, 3 under way, none of them phase 3. Osteoarthritis, Knee · University Hospital, Clermont-Ferrand.

Started
2024
with 1 other
No phase
5 of 13
1 open now
Registered
12th of 13
by date

Among the 13 studies in Osteoarthritis, Knee by University Hospital, Clermont-Ferrand, this one is one of 2 that started in 2024, is one of 5 with no phase, and was the 12th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

3 of the 13 studies in Osteoarthritis, Knee by University Hospital, Clermont-Ferrand are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Osteoarthritis, Knee by University Hospital, Clermont-Ferrand, or all of them as a file.
02

Study summary

The aim of this study is to compare the forgotten joint score for the medial pivot polyethylene and ultra-congruent polyethylene which are used in total prosthetic replacement of the knee

Read the detailed description

Total knee arthroplasty is usually effective at improving the quality of life of patients suffering from arthritis.

Over the years, patient expectations about the quality of life post-implantation continue to rise.

It is therefore essential to improve continuously surgical techniques and implants to fulfill patient expectations in terms of pain and movements.

The prosthetic device is composed of a metallic femoral unit, which imitates the articular surface of the femur, and a metallic tibial baseplate covered with a polyethylene (a highly resistant polymer) insert which articulates between the femur and the tibia. This insert can take several forms such as medial pivot or ultra-congruent.

This polymer provides an interface between the two metallic units forming the prothetic device. It has two roles: it provides a lasting contact surface and it offers stability to the knee in substitution of the ligaments.

In order to achieve this double function, a polyethylene system, called " medial pivot " was conceived.

This system mimics as close as possible the anatomical knee kinematics with a rotational movement that the " ball in socket " tries to reproduce by the mediatisation of the pivot point during knee flexion.

Currently, there are no randomized study which were conducted comparing these two types of polyethylene.

Total knee arthroplasty is usually effective at improving the quality of life of patients suffering from arthritis.

Over the years, patient expectations about the quality of life post-implantation continue to rise.

It is therefore essential to improve continuously surgical techniques and implants to fulfill patient expectations in terms of pain and movements.

The prosthetic device is composed of a metallic femoral unit, which imitates the articular surface of the femur, and a metallic tibial baseplate covered with a polyethylene (a highly resistant polymer) insert which articulates between the femur and the tibia. This insert can take several forms such as medial pivot or ultra-congruent.

This polymer provides an interface between the two metallic units forming the prothetic device. It has two roles: it provides a lasting contact surface and it offers stability to the knee in substitution of the ligaments.

In order to achieve this double function, a polyethylene system, called " medial pivot " was conceived.

This system mimics as close as possible the anatomical knee kinematics with a rotational movement that the " ball in socket " tries to reproduce by the mediatisation of the pivot point during knee flexion.

Currently, there are no randomized study which were conducted comparing these two types of polyethylene.

03

Conditions studied

  • Total Knee Replacement
  • Primary Knee Replacement
  • Gonarthrosis

Keywords

  • prospective
  • randomized study
  • parallel groups
  • forgotten joint score
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects 18 to 90 years of age, eligible for a primary total knee replacement for gonarthrosis
  • Competent subjects able to give to participate in the research
  • Affiliation to the social security system

Exclusion criteria

Exclusion criteria :

  • Infection history of the knee to be replaced
  • Deformity greater than 15 degrees
  • Any surgical and/or anesthetic , or any condition deemed by the investigator to be incompatible with the research.
  • Any contraindication mentioned in the instructions for use of the medical device
  • Pregnant or breastfeeding women
  • Recent infection history of the surgical site
  • Adults who are subject to a legal protection measure or who are unable to express their constent (Article L1121-8 of the French Public Health Code) and subjects under judicial protection (article L. 1122-2 FPHC)
  • Subjects who refuse to participate
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    medial pivot polyethylene

    Total knee replacement with medial pivot polyethylene

    Device: total knee arthroplasty with medial pivot polyethylene

  • Active comparator
    ultra-congruent polyethylene

    Total knee replacement with ultra-congruent polyethylene

    Device: total knee arthroplasty with ultra-congruent polyethylene

Interventions

  • Devicetotal knee arthroplasty with medial pivot polyethylene

    total knee arthroplasty with medial pivot polyethylene

  • Devicetotal knee arthroplasty with ultra-congruent polyethylene

    total knee arthroplasty with ultra-congruent polyethylene

06

What researchers measure

Primary outcomes

  1. evaluation of the forgotten joint score (FJS12)

    Forgotten knee score at 6 weeks (FJS-12, evaluated out of 100), which allows the analysis of quality of life specifically in relation to knee pathologies

    Time frame: Day 45

  2. evaluation of the forgotten joint score (FJS12)

    Forgotten knee score at 6 weeks (FJS-12, evaluated out of 100), which allows the analysis of quality of life specifically in relation to knee pathologies

    Time frame: Month 12

Secondary outcomes

  1. knee joint mobility

    Measurement of mobility in degrees (scale from 0 to 10)

    Time frame: Day -1

  2. knee joint mobility

    Measurement of mobility in degrees (scale from 0 to 10)

    Time frame: Day 45

  3. knee joint mobility

    Measurement of mobility in degrees (scale from 0 to 10)

    Time frame: month 12

  4. pain assessment

    assessment with a numeric pain rating scale ranging from 0 (none) to 10 (severe pain)

    Time frame: Day -1

  5. pain assessment

    assessment with a numeric pain rating scale ranging from 0 (none) to 10 (severe pain)

    Time frame: day 45

  6. pain assessment

    assessment with a numeric pain rating scale ranging from 0 (none) to 10 (severe pain)

    Time frame: month 12

  7. the Knee Society Score (KSS)

    the KSS (free of charge) scoring system is divided into 2 subcategories: a clinical score (maximum of 100 points) and a functional score (maximum of 100 points)

    Time frame: Day -1

  8. the Knee Society Score (KSS)

    the KSS (free of charge) scoring system is divided into 2 subcategories: a clinical score (maximum of 100 points) and a functional score (maximum of 100 points)

    Time frame: Day 45

  9. the Knee Society Score (KSS)

    the KSS (free of charge) scoring system is divided into 2 subcategories: a clinical score (maximum of 100 points) and a functional score (maximum of 100 points)

    Time frame: month 12

  10. Knee injury and Osteoarthritis Outcome Score Physical Function Short form (KOOS-PS).

    the KOOS-PS (free of charge) is used to assess the postoperative quality of life related to knee joint pathologies.

    Time frame: day -1

  11. Knee injury and Osteoarthritis Outcome Score Physical Function Short form (KOOS-PS).

    the KOOS-PS (free of charge) is used to assess the postoperative quality of life related to knee joint pathologies.

    Time frame: Day 45

  12. Knee injury and Osteoarthritis Outcome Score Physical Function Short form (KOOS-PS).

    the KOOS-PS (free of charge) is used to assess the postoperative quality of life related to knee joint pathologies.

    Time frame: Month 12

  13. radiographic alignment

    measurement of the anteroposterior radiographic alignment at 1 year post-operative using the Hip-knee-ankle (HKA) angle

    Time frame: month 12

  14. radiological complications

    Peri- and post-operative complications using standard radiographic analysis (static radiographs of the lower limbs, anteroposterior and lateral knee radiographs, patellofemoral view at 45°)

    Time frame: Day -1

  15. radiological complications

    Peri- and post-operative complications using standard radiographic analysis (static radiographs of the lower limbs, anteroposterior and lateral knee radiographs, patellofemoral view at 45°)

    Time frame: Day 45

  16. radiological complications

    Peri- and post-operative complications using standard radiographic analysis (static radiographs of the lower limbs, anteroposterior and lateral knee radiographs, patellofemoral view at 45°)

    Time frame: Month 12

07

Study locations

1 of 1 sites recruiting
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting
    • Lise Laclautre · Contact
    • Stéphane DESCAMPS · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Mar 2027, 33 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 33 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2024
First posted
Nov 6, 2024
StartActual
Jun 4, 2024
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Jan 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06676189
Responsible party
Sponsor
First posted
Nov 6, 2024
Start date
Jun 4, 2024
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Jan 17, 2025

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334.73.754.963
Stéphane DESCAMPS
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion